Thyroid Cancer Information Center
Each year in the United States, more than 37,000 people are diagnosed with thyroid cancer. It is estimated that there are more than 388,000 thyroid cancer survivors living in the U.S. today.
Advances in surgery and radioactive iodine treatment have contributed to high rates of thyroid cancer survival. In addition, advances in supportive care have made thyroid cancer treatment more tolerable, leading to improved quality of life.
Understanding thyroid cancer treatment options, the role of different doctors specializing in the treatment of thyroid cancer, and how and when to access new and innovative thyroid cancer treatment options available through clinical trials is essential in order to achieve the best outcome from thyroid cancer treatment.
The Cancer Consultants Thyroid Cancer Information Center has been designed to help patients understand thyroid cancer and thyroid cancer treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of thyroid cancer.
Headline Thyroid Cancer News 
Childhood Cancer Survivors at Risk for Thyroid Cancer
Survivors of childhood cancer at risk of developing thyroid cancer
Targeted Radiotherapy Shows
According to results from a Phase II clinical trial, use of targeted radiation...
Thyroid Cancer Tips
Thyroid Cancer Risk Factors Certain factors may increase an individual’s likelihood of developing thyroid...
Thyroid Cancer Prevention Although it’s not possible to prevent thyroid cancer, the following measures may...
Diagnosing Thyroid Cancer Although thyroid cancer is essentially symptomless, if you see or feel any lumps...
Thyroid Cancer Management
Inspiration, Hope & Resources
On Top of the World: Climbing Everest & Beating Cancer Twice Sean Swarner is a master of setting a goal and achieving it. So when he...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Thyroid Cancer Clinical Trials
E-5-05 – Phase II Study of Decitabine in Patients with Metastatic Papillary Thyroid Cancer of Follicular Thyroid Cancer Unresponsive to Radioiodine.
REFMAL28-T – A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-T
20050130 – An Open Label Treatment Extension Study of AMG 706
 |
 |
 |
 |
